Patient Conversations Reveal Critical Gaps Between GLP-1 Clinical Efficacy and Real-World Sustainability
THE QUESTION What do patient conversations reveal about the real-world experience of GLP-1 weight loss treatment? Nearly 12 percent of Americans have used GLP-1 drugs for weight loss, according to the RAND report “New Weight Loss Drugs” from August 6, 2025. This rapid adoption raises urgent questions: Why do patients discontinue treatment? How are they […]




